Skip to main content

Advertisement

Log in

Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The goal of this study was to determine the prevalence of fluoroquinolone resistance in Streptococcus agalactiae and the serotype distribution of this resistant bacterium. S. agalactiae strains collected from 221 asymptomatic pregnant women (35–37 weeks of gestation) and 838 patients with S. agalactiae infection in Korea, from 2006 to 2008, were tested for susceptibility to four fluoroquinolones. Rates of resistance of S. agalactiae to ciprofloxacin, levofloxacin, and moxifloxacin were 9.3 %, 9.5 %, and 0.8 %, respectively; greater than 94 % of S. agalactiae strains were resistant to norfloxacin. Resistance to ciprofloxacin and levofloxacin increased between 2006 and 2008. All strains were susceptible to penicillin. Resistance to ciprofloxacin and levofloxacin was higher in the clinical strains of S. agalactiae isolated from infections than in colonizing strains isolated from pregnant women. Mutations in the quinolone resistance-determining regions of gyrase and topoisomerase genes were detected in strains resistant to ciprofloxacin, levofloxacin, and moxifloxacin; no such mutations were found in strains resistant only to norfloxacin. There was a strong correlation between the minimum inhibitory concentrations and the presence of mutations in gyrase and topoisomerase genes. In conclusion, the prevalence of fluoroquinolone resistance was unexpectedly high. Strain serotypes were not associated with susceptibility to fluoroquinolones.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gibbs RS, Schrag S, Schuchat A (2004) Perinatal infections due to group B streptococci. Obstet Gynecol 104(5 Pt 1):1062–1076. doi:10.1097/01.AOG.0000144128.03913.c2

    Article  PubMed  Google Scholar 

  2. Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, Oh KY, Yoon HR, Pai SY, Foxman B, Ki M (2010) Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 138(2):292–298. doi:10.1017/S0950268809990859

    Article  PubMed  CAS  Google Scholar 

  3. Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC (1997) Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis 16(10):753–756

    Article  PubMed  CAS  Google Scholar 

  4. Kim M, Jang H, Chang D, Cho J, Kim Y, Choi H, Kim S, Lee J, Hwang K, Kang B (2006) Group B streptococcal colonization rate in Korean pregnant women. Korean J Obstet Gynecol 49(2):337–344

    Google Scholar 

  5. Choi K, Koh S, Lee J, Park J, Hwang S, Lee B, Lee W (2002) Clinical significance of group B streptococcal infection in pregnant women. Korean J Obstet Gynecol 45(5):811–815

    Google Scholar 

  6. Lee J, Kim S, Lee H, Kim S, Choi S, Sung I, Kang J, Chun C (2003) A clinical study of group B streptococcal infection: five years experience. J Korean Soc Neonatol 10(2):226–234

    Google Scholar 

  7. Scheld WM (2003) Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 9(1):1–9

    Article  PubMed  CAS  Google Scholar 

  8. Hooper DC (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2(9):530–538

    Article  PubMed  CAS  Google Scholar 

  9. Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, Itoh Y, Ezaki T (2003) First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob Agents Chemother 47(11):3605–3609

    Article  PubMed  CAS  Google Scholar 

  10. Biedenbach DJ, Toleman MA, Walsh TR, Jones RN (2006) Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 55(2):119–127

    Article  PubMed  CAS  Google Scholar 

  11. Wu HM, Janapatla RP, Ho YR, Hung KH, Wu CW, Yan JJ, Wu JJ (2008) Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 52(5):1888–1890

    Article  PubMed  CAS  Google Scholar 

  12. von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R (2003) A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J Clin Microbiol 41(5):2166–2169

    Article  Google Scholar 

  13. Ulett KB, Benjamin WH Jr, Zhuo F, Xiao M, Kong F, Gilbert GL, Schembri MA, Ulett GC (2009) Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol 47(7):2055–2060. doi:10.1128/JCM.00154-09

    Article  PubMed  Google Scholar 

  14. Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN, Doern GV (2000) Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 183(4):859–862. doi:10.1067/mob.2000.108839

    Article  PubMed  CAS  Google Scholar 

  15. Brueggemann AB, Coffman SL, Rhomberg P, Huynh H, Almer L, Nilius A, Flamm R, Doern GV (2002) Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob Agents Chemother 46(3):680–688

    Article  PubMed  CAS  Google Scholar 

  16. Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, Yang JH, Yoon HR, Miller B, DeBusscher J, Foxman B, Ki M (2010) Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci 25(6):817–823. doi:10.3346/jkms.2010.25.6.817

    Article  PubMed  CAS  Google Scholar 

  17. National Committee for Clinical Laboratory Standards (NCCLS) (2002) Performance Standards for Antimicrobial Susceptibility Testing, vol M100–S12. Table 2 H. Wayne, PA, USA

    Google Scholar 

  18. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF (2004) Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 42(1):146–150

    Article  PubMed  CAS  Google Scholar 

  19. Zhang L, Reddi U, Srinivasan U, Li S, Borchardt SM, Pillai P, Mehta P, Styka AN, Debusscher J, Marrs CF, Foxman B (2008) Combining microarray technology and molecular epidemiology to identify genes associated with invasive group B streptococcus. Interdiscip Perspect Infect Dis 2008(314762):1–10. doi:10.1155/2008/314762

    Article  Google Scholar 

  20. Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B (2004) Library on a slide for bacterial comparative genomics. BMC Microbiol 4:12. doi:10.1186/1471-2180-4-12

    Article  PubMed  Google Scholar 

  21. Marrs CF, Zhang L, Tallman P, Manning SD, Somsel P, Raz P, Colodner R, Jantunen ME, Siitonen A, Saxen H, Foxman B (2002) Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol 51(2):138–142

    PubMed  CAS  Google Scholar 

  22. Harris TO, Shelver DW, Bohnsack JF, Rubens CE (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111(1):61–70. doi:10.1172/JCI16270

    PubMed  CAS  Google Scholar 

  23. Bhavnani SM, Hammel JP, Jones RN, Ambrose PG (2005) Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis 51(1):31–37

    Article  PubMed  CAS  Google Scholar 

  24. Tazi A, Gueudet T, Varon E, Gilly L, Trieu-Cuot P, Poyart C (2008) Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg Infect Dis 14(2):349–350

    Article  PubMed  Google Scholar 

  25. Wehbeh W, Rojas-Diaz R, Li X, Mariano N, Grenner L, Segal-Maurer S, Tommasulo B, Drlica K, Urban C, Rahal JJ (2005) Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob Agents Chemother 49(6):2495–2497

    Article  PubMed  CAS  Google Scholar 

  26. Fuller JD, Low DE (2005) A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 41(1):118–121. doi:10.1086/430829

    Article  PubMed  Google Scholar 

  27. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, Klugman KP (2004) Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 48(9):3491–3497. doi:10.1128/AAC.48.9.3491-3497.2004

    Article  PubMed  CAS  Google Scholar 

  28. Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev: MMBR 61(3):377–392

    PubMed  CAS  Google Scholar 

  29. Pestova E, Millichap JJ, Noskin GA, Peterson LR (2000) Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother 45(5):583–590

    Article  PubMed  CAS  Google Scholar 

  30. Takei M, Fukuda H, Kishii R, Hosaka M (2001) Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob Agents Chemother 45(12):3544–3547. doi:10.1128/AAC.45.12.3544-3547.2001

    Article  PubMed  CAS  Google Scholar 

  31. Baranova NN, Neyfakh AA (1997) Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae. Antimicrob Agents Chemother 41(6):1396–1398

    PubMed  CAS  Google Scholar 

  32. Jumbe NL, Louie A, Miller MH, Liu W, Deziel MR, Tam VH, Bachhawat R, Drusano GL (2006) Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 50(1):310–317. doi:10.1128/AAC.50.1.310-317.2006

    Article  PubMed  CAS  Google Scholar 

  33. Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19(2):382–402. doi:10.1128/CMR.19.2.382-402.2006

    Article  PubMed  CAS  Google Scholar 

  34. Tran JH, Jacoby GA, Hooper DC (2005) Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49(1):118–125

    Article  PubMed  CAS  Google Scholar 

  35. Rodriguez-Martinez JM, Velasco C, Briales A, Garcia I, Conejo MC, Pascual A (2008) Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother 61(6):1240–1243. doi:10.1093/jac/dkn115

    Article  PubMed  CAS  Google Scholar 

  36. Ince D, Hooper DC (2003) Quinolone resistance due to reduced target enzyme expression. J Bacteriol 185(23):6883–6892

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the Seoul Clinical Laboratories, the Seoul Medical Science Institute, and the following physicians for providing some of the isolates used in this study: Jung Yeol Han, Hyun-Mi Ryu, and Hyun-Kyong Ahn (Cheil General Hospital & Women's Healthcare Center, Kwandong University, Seoul); In-Tack Hwang and Jung-Hun Rho (Eulji University Hospital, Daejeon); and Seo-Yoo Hong and Won-Il Park (Eulji Hospital, Seoul). This work was supported by a Korea Research Foundation Grant funded by the Korean Government (KRF-2009-0074540).

Conflict of interest

All authors claim no commercial or other association that might pose a conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Ki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ki, M., Srinivasan, U., Oh, K.Y. et al. Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea. Eur J Clin Microbiol Infect Dis 31, 3199–3205 (2012). https://doi.org/10.1007/s10096-012-1685-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-012-1685-8

Keywords

Navigation